Clinical studies have shown decreased IGFBP-2 levels in both maternal and cord blood in GDM pregnancies (82, 87), leading to an augment of biologically active IGF-1 and IGF-2 that accelerates fetal growth. Here, IGF2 is linked to gestational diabetes.